151 results on '"Anand, Sarah"'
Search Results
2. Pneumocystis jirovecii Infection in autologous hematopoietic stem cell transplant recipients
3. Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions
4. A phase 2 trial of CD24Fc for prevention of graft-versus-host disease
5. Cardiovascular Events After Hematopoietic Stem Cell Transplant: Incidence and Risk Factors
6. Type 1 interferon to prevent leukemia relapse after allogeneic transplantation
7. Incidence of Restrictive Lung Disease Following Autologous Stem Cell Transplantation for High Risk Lymphoma
8. Rational Modification of Human Gut Microbiome and Metabolites By Dietary Resistant Starch in Allogeneic Hematopoietic Stem Cell Transplantation to Mitigate Acute Graft Versus Host Disease: A Phase II Study Clinical Update
9. MODULAATE (Part 1): An Open-Label, Dose-Finding Phase 2 Evaluation of Alpha-1 Antitrypsin for the Prevention of Graft-Versus-Host Disease in Patients Receiving Hematopoietic Cell Transplantation
10. Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin's lymphoma.
11. Heightened TLR7 Primes BCR-Activated Cells in Chronic Graft-Versus-Host Disease for Effector Functions
12. Director-Led Investigations : Maximizing Efficiency and Minimizing Business Disruption
13. A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease
14. Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant
15. Assessment of Individual versus Composite Endpoints of Acute Graft-versus-Host Disease in Determining Long-Term Survival after Allogeneic Transplantation
16. A Phase 2 Trial of CD24Fc for Prevention of Graft-vs-Host Disease
17. An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD
18. Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning
19. Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization
20. A secondary CD34 + acute lymphoblastic leukemia unmasked and mobilized by G‐CSF in an autologous stem cell donor with testicular cancer
21. Pneumocystis jirovecii Infection in autologous hematopoietic stem cell transplant recipients
22. A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease
23. Neihulizumab (ALTB-168) in Patients with Steroid-Refractory Acute Graft-Versus-Host-Disease (SR-aGVHD) or Treatment-Refractory Acute Graft-Versus-Host-Disease (TR-aGVHD)
24. A secondary CD34+ acute lymphoblastic leukemia unmasked and mobilized by G‐CSF in an autologous stem cell donor with testicular cancer.
25. DIRECTOR-LED INVESTIGATIONS
26. MODULAATE, A 2-Part, Dose-Finding, Efficacy and Safety Trial with Alpha-1 Antitrypsin (AAT) for Prevention of Acute Graft vs. Host Disease (aGVHD): Part 1 Safety and Pharmacokinetic (PK) Results
27. Use of Siltuximab for the Treatment of Severe Immune Effector Cell Neurotoxicity Syndrome Following Chimeric Antigen Receptor T-Cell Therapy: Single Center Case Series
28. Pneumocystis jiroveciiInfection in autologous hematopoietic stem cell transplant recipients
29. Pneumocystis Jirovecii Infection in Autologous Hematopoietic Stem Cell Transplant Recipients
30. Long-term follow-up of adult hematopoietic stem cell transplant recipients diagnosed with COVID-19.
31. Characterizing advance care planning, palliative care utilization, and location of end-of-life for adult allogeneic hematopoietic stem cell transplant recipients.
32. BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation
33. Safety Analysis of Patients Who Received Ruxolitinib for the Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease in an Expanded Access Program
34. Mitigating Damage Response with CD24 Fusion Protein for Prevention of Acute Graft-Versus-Host Disease
35. Targeting Danger Associated Molecular Pattern (DAMP) with CD24Fc to Reduce Acute Gvhd: Study Design on a Randomized Double Blind Placebo Controlled Phase III Clinical Trial (CATHY Study)
36. Rational Modification of Intestinal Microbiome and Metabolites after Allogeneic Hematopoietic Stem Cell Transplantation with Resistant Starch: A Pilot Study
37. Evaluation of the Oral SYK Inhibitor Fostamatinib in Patients after Allogeneic Transplantation for Chronic Graft-Versus-Host Disease
38. 376 - MODULAATE, A 2-Part, Dose-Finding, Efficacy and Safety Trial with Alpha-1 Antitrypsin (AAT) for Prevention of Acute Graft vs. Host Disease (aGVHD): Part 1 Safety and Pharmacokinetic (PK) Results
39. 218 - Use of Siltuximab for the Treatment of Severe Immune Effector Cell Neurotoxicity Syndrome Following Chimeric Antigen Receptor T-Cell Therapy: Single Center Case Series
40. A Phase I/II Clinical Trial of Type 1 Interferon for Reduction of Relapse after HCT in High Risk AML
41. Ultrasensitive Genomic Minimal Residual Disease Detection in Peripheral Blood after Allogeneic HSCT for MDS Is Associated with Increased Relapse Risk and Inferior Survival
42. Impact of Individual Vs. Composite Endpoints for Prediction of Long-Term Survival in Gvhd Clinical Trials Research
43. The Effect of Azithromycin on Relapse in Patients with Moderate-Severe Chronic Graft Versus Host Disease (CGVHD)
44. Serial Biomarker Monitoring Early after HCT Identifies Different Risks for Relapse and Graft-Vs-Host Disease
45. Chronic Graft-versus-Host Disease: A Long Road Ahead
46. Increased TLR7 Signaling of BCR-Activated B Cells in Chronic Graft-Versus Host Disease (cGVHD)
47. Bruised Black and Blue: Acquired Hypoprothrombinemia
48. Recipient-Derived BAFF and Alloantigen Synergistically Activate B Cells in Murine Chronic Gvhd
49. All-Trans Retinoic Acid (ATRA) Targets IRF4 Deficient, NOTCH2-Activated B Cells from Chronic Gvhd Patients
50. Adult Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation, Fludarabine, and Thiotepa Conditioning
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.